FDA Panel Rejects AstraZeneca Drug
22799
A U.S. panel of medical experts recommended on Friday that U.S. regulators reject AstraZeneca's   application to sell its anti-clotting drug Exanta.
112661
A U.S. advisory panel  urged the government on Thursday to reject Merck & Co Inc's   latest bid to sell the first cholesterol-lowering drug  without a prescription.
397739
A top official of the US Food and Drug Administration said Friday that he and his colleagues &quot;categorically reject&quot; earlier Congressional testimony that the agency has failed to protect the public against dangerous drugs.
247888
AstraZeneca will defend its new prescription drug Exanta before a federal panel today after new questions were raised about the safety and effectiveness of the stroke prevention medication.
585919
The company withdrew its application to gain federal approval for a weight loss drug after a meeting at which government advisers rejected the treatment on safety grounds.
426995
AstraZeneca Plc suffered its third  setback in two months on Friday as lung cancer drug Iressa  failed to help patients live longer in a major clinical trial,  sending its shares down more than 8 percent.
207035
AstraZeneca Plc has withdrawn its  marketing application for lung cancer pill Iressa in Europe  after the drug failed to help patients live longer in a  clinical study, Europe's third largest drugmaker said on  Tuesday.
691286
Drug maker AstraZeneca PLC said Friday that the Food and Drug Administration did not approve its orally taken blood thinner Exanta.
278822
A weight loss drug used widely in the UK is rejected by US safety officials over fears of an increased suicide risk.
106113
Shares in AstraZeneca tumbled today after a key drug it has developed in the fight against strokes was provisionally rejected by US regulators.
638956
AstraZeneca Plc  is convinced  it can prevail in U.S. patent disputes over its two biggest  drugs, Nexium and Seroquel, and has had no discussions about  settling the cases, its chief executive said on Wednesday.
671791
Federal regulators did not act on a recommendation from their safety reviewers about the risk of heart attacks for the diabetes drug Avandia.
79616
AstraZeneca Plc, the UK&#39;s second largest drugmaker, said US regulators approved its ulcer treatment Nexium for use in reducing the risk of stomach ulcers in patients taking certain painkillers
14666
A US advisory panel on Friday recommended against approving AstraZeneca&#39;s new stroke prevention medication, Exanta, citing concerns about the drug&#39;s effect on the liver.
579894
Twenty-nine patients who took AstraZeneca Plc's  cholesterol drug Crestor have developed kidney damage, a U.S. consumer group said on Friday as it called again for a ban on the medicine.
512456
NEW YORK, September 9 (New Ratings) - The FDA has raised questions regarding AstraZenecaâs (AZN.NYS) blood thinner, Exanta. The leading pharmaceutical companyâs hopes had been pinned on Exanta, which
678265
Twenty-nine patients who took AstraZeneca Plc's   anti-cholesterol drug Crestor have developed kidney damage, a U.S. consumer group said on Friday as it called again for a ban on the medicine.